Hennessy Advisors Inc Pfizer Inc Transaction History

Hennessy Advisors Inc

$2.92 Billion
Q2 2025

A detailed history of Hennessy Advisors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Hennessy Advisors Inc holds 208,100 shares of PFE stock, worth $5.16 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

208,100

Previous 208,100 -0.0%

Holding current value

$5.16 Million

Previous $5.27 Million 4.34%

% of portfolio

0.17%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$25.01 - $27.13 $857,843 - $930,559	34,300 Added 19.74%	208,100 $5.27 Million
Q4 2024 Jan 14, 2025	SELL	$24.8 - $30.19 $156,240 - $190,197	-6,300 Reduced 3.5%	173,800 $4.61 Million
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $93,462 - $109,520	-3,700 Reduced 2.01%	180,100 $5.04 Million
Q1 2024 Apr 15, 2024	BUY	$25.89 - $29.73 $4.76 Million - $5.46 Million	183,800 New	183,800 $5.1 Million
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $177,684 - $230,791	-6,800 Reduced 3.67%	178,600 $5.14 Million
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $134,778 - $157,542	-4,200 Reduced 2.22%	185,400 $6.15 Million
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $321,468 - $371,931	-8,900 Reduced 4.48%	189,600 $6.95 Million
Q1 2023 Apr 14, 2023	BUY	$39.39 - $51.28 $3.53 Million - $4.6 Million	89,700 Added 82.44%	198,500 $8.1 Million
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $83,500 - $109,000	-2,000 Reduced 1.81%	108,800 $5.58 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $52,512 - $64,104	1,200 Added 1.09%	110,800 $4.85 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $1.07 Million - $1.32 Million	-23,300 Reduced 17.53%	109,600 $5.67 Million
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $128,092 - $189,875	-3,100 Reduced 2.28%	132,900 $7.85 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $82,425 - $105,882	-2,100 Reduced 1.52%	136,000 $5.85 Million
Q2 2021 Jul 28, 2021	SELL	$35.91 - $40.68 $174,163 - $197,298	-4,850 Reduced 3.39%	138,100 $5.41 Million
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $1.2 Million - $1.36 Million	-35,950 Reduced 20.1%	142,950 $5.18 Million
Q4 2020 Jan 25, 2021	SELL	$33.47 - $42.56 $2.15 Million - $2.74 Million	-64,300 Reduced 26.44%	178,900 $6.59 Million
Q3 2020 Oct 16, 2020	SELL	$31.75 - $37.25 $915,987 - $1.07 Million	-28,850 Reduced 10.6%	243,200 $8.93 Million
Q2 2020 Jul 20, 2020	SELL	$30.12 - $36.54 $263,550 - $319,725	-8,750 Reduced 3.12%	272,050 $8.9 Million
Q1 2020 Apr 14, 2020	BUY	$27.03 - $38.62 $764,949 - $1.09 Million	28,300 Added 11.21%	280,800 $9.17 Million
Q4 2019 Jan 14, 2020	BUY	$32.92 - $37.36 $39,504 - $44,832	1,200 Added 0.48%	252,500 $9.89 Million
Q3 2019 Oct 07, 2019	SELL	$32.49 - $42.13 $34,114 - $44,236	-1,050 Reduced 0.42%	251,300 $9.03 Million
Q2 2019 Jul 11, 2019	SELL	$36.98 - $41.52 $445,608 - $500,316	-12,050 Reduced 4.56%	252,350 $10.9 Million
Q1 2019 Apr 08, 2019	SELL	$37.5 - $41.2 $984,450 - $1.08 Million	-26,252 Reduced 9.03%	264,400 $11.2 Million
Q4 2018 Jan 14, 2019	SELL	$38.47 - $43.86 $407,782 - $464,916	-10,600 Reduced 3.52%	290,652 $12.7 Million
Q3 2018 Oct 10, 2018	SELL	$34.47 - $41.81 $477,409 - $579,068	-13,850 Reduced 4.4%	301,252 $13.3 Million
Q2 2018 Jul 20, 2018	SELL	$32.98 - $35.16 $186,336 - $198,653	-5,650 Reduced 1.76%	315,102 $11.4 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $110,153 - $127,793	3,452 Added 1.09%	320,752 $11.4 Million
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $164,637 - $174,685	-4,950 Reduced 1.54%	317,300 $11.5 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $9.99 Million - $11 Million	322,250	322,250 $11.5 Million

Others Institutions Holding PFE

# of Institutions

3,361

Shares Held

3.6B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hennessy Advisors Inc with notifications on news.

Account

Hennessy Advisors Inc Pfizer Inc Transaction History